Correlation Between Spyre Therapeutics and 25160PAH0
Specify exactly 2 symbols:
By analyzing existing cross correlation between Spyre Therapeutics and DB 2552 07 JAN 28, you can compare the effects of market volatilities on Spyre Therapeutics and 25160PAH0 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of 25160PAH0. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and 25160PAH0.
Diversification Opportunities for Spyre Therapeutics and 25160PAH0
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Spyre and 25160PAH0 is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and DB 2552 07 JAN 28 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DB 2552 07 and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with 25160PAH0. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DB 2552 07 has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and 25160PAH0 go up and down completely randomly.
Pair Corralation between Spyre Therapeutics and 25160PAH0
Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the 25160PAH0. In addition to that, Spyre Therapeutics is 4.21 times more volatile than DB 2552 07 JAN 28. It trades about -0.08 of its total potential returns per unit of risk. DB 2552 07 JAN 28 is currently generating about -0.2 per unit of volatility. If you would invest 9,506 in DB 2552 07 JAN 28 on November 6, 2024 and sell it today you would lose (301.00) from holding DB 2552 07 JAN 28 or give up 3.17% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 94.74% |
| Values | Daily Returns |
Spyre Therapeutics vs. DB 2552 07 JAN 28
Performance |
| Timeline |
| Spyre Therapeutics |
| DB 2552 07 |
Spyre Therapeutics and 25160PAH0 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spyre Therapeutics and 25160PAH0
The main advantage of trading using opposite Spyre Therapeutics and 25160PAH0 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, 25160PAH0 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 25160PAH0 will offset losses from the drop in 25160PAH0's long position.| Spyre Therapeutics vs. CytomX Therapeutics | Spyre Therapeutics vs. Instil Bio | Spyre Therapeutics vs. Spero Therapeutics | Spyre Therapeutics vs. Assembly Biosciences |
| 25160PAH0 vs. AEP TEX INC | 25160PAH0 vs. US BANK NATIONAL | 25160PAH0 vs. Reliance Global Group | 25160PAH0 vs. Bayerische Motoren Werke |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |